Showing results (301-310 of 3,282) with videos related to
Sort By:
Pageof 329
Cutaneous and Ocular Toxicology|May 2, 2023
Evaluation of uveitis events in real-world patients receiving immune checkpoint inhibitors based on the FAERS databaseQianqian Fan, Huan Chen, Yang Hu, et al.Molecules (Basel, Switzerland)|April 28, 2023
Theoretical Study of Phase Behaviors of Symmetric Linear B1A1B2A2B3 Pentablock CopolymerBin Zhao, Qingshu Dong, Wei Yang, et al.Annals of Palliative Medicine|August 14, 2020
Drug discovery in cardiovascular disease identified by text mining and data analysisZheng Wan, Bin Zhao, Xiaohong Zhang, et al.Microbiology Resource Announcements|May 22, 2023
Complete Genome Sequence of Bifidobacterium animalis subsp. lactis BLa80, a Strain Isolated from Human Breast MilkMingming Zhu, Jianguo Zhu, Shuguang Fang, et al.Molecular Medicine Reports|May 26, 2021
miR‑135a‑5p inhibits tumor invasion by targeting ANGPT2 in gallbladder cancerHaiyan Diao, Xing Xu, Bin Zhao, et al.Frontiers in Medicine|January 7, 2026
Cumulative estimated glucose disposal rate predicts frailty progression in Chinese adults with diabetes: a 9-year follow-up cohort studyBin Zhao, Zhian Liang, Xiaojie Zhao, et al.Frontiers in Immunology|August 6, 2025
Early immunotherapy in a patient with myelin oligodendrocyte glycoprotein antibody-associated disease with syphilis and acquired immunodeficiency syndrome: a case reportQiu-Xia Zhang, Lin-Jie Zhang, Bin ZhaoScientific Reports|March 14, 2025
Robot multi-target high performance grasping detection based on random sub-path fusionBin Zhao, Lianjun Chang, Chengdong Wu, et al.International Journal of Cancer|March 11, 2025
Eosinophil-induced adverse events induced by treatment with programmed cell death 1/ligand 1 inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting systemLu Lyu, Sainan Bian, Kai Guan, et al.Head & Neck|March 12, 2025
A Case of a Huge Left Common Carotid Artery Paraganglioma Resected With the Left Thyroid GlandJiaxi Pu, Shaofei Yang, Minhao Lu, et al.Pageof 329